Marian McNeil (Precision Medicine Scotland Innovation Centre (PMS-IC) (formerly the Stratified Medicine Scotland Innovation Centre))

McNeil, Marian (Precision Medicine Scotland Innovation Centre 202208 CEO)

	Organisation	Precision Medicine Scotland Innovation Centre (PMS-IC) (formerly the Stratified Medicine Scotland Innovation Centre)
	Product	personalised medicine / precision medicine
	Product 2	business development (state/region)

Precision Medicine Scotland Innovation Centre (PMS-IC). (8/25/22). "Press Release: Up to £300,000 Available from Precision Medicine Scotland Innovation Centre to Support Researchers across Scotland". Basel.

> New fund launched for research into accurate diagnosis and treatment of disease

> Aimed at novel research to identify predictors of disease and optimal treatment.

Precision Medicine Scotland Innovation Centre (PMS-IC), the national centre for accelerating the advancement and adoption of precision medicine, has today launched a new fund to support Scottish researchers. The fund, the first offered by PMS-IC, will support research ideas to support accurate diagnosis and/or treatment based on an individual’s unique biology.

Funds of up to £30,000 will be available for a maximum of ten projects. Applicants will need to demonstrate how their work will advance precision medicine and the fund will support work involving collaborations with the NHS, academia and industry.

The fund will help support a new pipeline of tangible ideas to harness the potential of precision medicine in Scotland. The fund is aimed at research-led opportunities for Scottish University or College based researchers.

Precision Medicine Scotland is looking for ideas with a strong case for commercialisation. It is seeking applicants from a Scottish research funding university or college with an industry partner to provide match funding. For applicants looking to commercialise current research there must be a strong case of support from a business development specialist.

Marian McNeil, Chief Executive, Precision Medicine Scotland Innovation Centre, said:

“We have designed this fund to help discover new innovation in precision medicine which can be adopted across the NHS in Scotland and the wider global economy. We are passionate about supporting new talent and we want to provide the impetus to accelerate the adoption of precision medicine in healthcare. Our aim is to support researchers who are already engaged in work that can change and save people’s lives.

“We look forward to reviewing the high quality project proposals and to helping foster existing ideas that can make use of this fund to transform innovative research into tangible commercial outcomes that benefit patients.”

The deadline for submissions is the 23rd of September and successful applicants will be announced on 26th October. The Business Development Team at Precision Medicine Scotland will be available to discuss ideas with potential applicants. Proposals are to be submitted to: admin@precisionmedicinescotland.com Details of the fund and forms are available from PMS-IC’s website https://www.precisionmedicinescotland.com/2022/08/seed-funding-call-researches-can-apply-for-up-to-30000/

Ends

Notes to editors:

About Precision Medicine Scotland

PMS-IC was formed by the Scottish Funding Council (SFC) in 2013 and since its inception, the Scotland-wide hub has been working with industry, academia, health charities, the NHS and government to collaborate to tackle the significant healthcare challenges that society faces. Its key projects cover conditions such as: Ovarian Cancer, MS, Oesophageal Cancer, COPD, Rheumatoid Arthritis and Pancreatic Cancer. PMS-IC also delivers large scale collaborative informatics programmes with its industrial partners.